Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Epigenomes|December 30, 2021
Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary CholangitisPinelopi Arvaniti, Kalliopi Zachou, Aggeliki Lyberopoulou, et al.
Annals of Hepatology|November 6, 2020
FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseasesKalliopi Zachou, Vasiliki Lygoura, Pinelopi Arvaniti, et al.
Journal of Translational Autoimmunity|December 31, 2025
Cell-specific epigenome-wide DNA methylation in peripheral CD4(+) lymphocytes from patients with primary biliary cholangitisPinelopi Arvaniti, Kalliopi Zachou, Aggeliki Lyberopoulou, et al.
Frontiers in Immunology|January 28, 2022
First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH PatientsGeorge N Dalekos, Pinelopi Arvaniti, Nikolaos K Gatselis, et al.
Clinical Reviews in Allergy & Immunology|June 6, 2019
JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's SyndromeAmandine Charras, Pinelopi Arvaniti, Christelle Le Dantec, et al.
Clinical Immunology (Orlando, Fla.)|November 26, 2019
Linking genetic variation with epigenetic profiles in Sjögren's syndromePinelopi Arvaniti, Christelle Le Dantec, Amandine Charras, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2022
Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitisKalliopi Zachou, Pinelopi Arvaniti, Aggeliki Lyberopoulou, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2022
Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitisGeorge N Dalekos, Pinelopi Arvaniti, Nikolaos K Gatselis, et al.
Pageof 3